Most common infectious diseases pneumonia and influenza. »
12/31/21

Progression-free (PFS) and overall survival (OS) similar between the two cohorts. »
09/25/21

Re-diSe, but not diSe affected viability of malignant cells. »
09/06/21

Study supports aflibercept plus FOLFIRI benefits. »
05/12/21

Overweight and obese bladder cancer patients had better outcomes within first five years. »
12/23/21

Skin cancer treatment delay, due to COVID-19 pandemic, related to increased incidence of SCC. »
12/24/21

CD138 + immune cells that more prevalent in patients with worse prognosis. »
12/24/21

Bacterial abundance significantly different between groups. »
12/23/21

Higher concentration of E. faecalis and ETBF in FFPE samples of CRC patients than controls. »
12/22/21

Epigenetic modulating agents may coordinately promote tumor immunogenicity. »
12/20/21